The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease

David I. Finkelstein(University of Melbourne), Robert A. Cherny(The University of Melbourne)
Acta Neuropathologica Communications
June 28, 2017
Cited by 99


Related Papers